Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis | Zendy

Rocío PérezIglesias | Zendy; Ignácio F. Mata | Zendy; Obdulia MartínezGarcía | Zendy; María Teresa GarcíaUnzueta | Zendy; José Amado | Zendy; Elsa M. Valdizán | Zendy; José Luis VázquezBarquero | Zendy; Benedicto CrespoFacorro | Zendy

Open Access

Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis

Author(s) -

Rocío PérezIglesias,

Ignácio F. Mata,

Obdulia MartínezGarcía,

María Teresa GarcíaUnzueta,

José Amado,

Elsa M. Valdizán,

José Luis VázquezBarquero,

Benedicto CrespoFacorro

Publication year - 2012

Publication title -

journal of clinical psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.786

H-Index - 121

eISSN - 1533-712X

pISSN - 0271-0749

DOI - 10.1097/jcp.0b013e318272688b

Subject(s) - risperidone , olanzapine , haloperidol , prolactin , psychology , medicine , psychosis , dopamine antagonist , population , schizophrenia (object oriented programming) , psychiatry , dopamine , hormone , environmental health

The main goal of this study was to assess the long-term effect of haloperidol, olanzapine, and risperidone on serum prolactin levels in a naturalistically treated first-episode psychosis population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research